Two veteran healthcare leaders are teaming up to launch BEVIMI, a brain health and wellness company unveiled at the inaugural CG Well Summit in New York. Co-founders Paul Jacobson, former CEO of Thorne HealthTech, and Joel Dudley, PhD, former Chief Scientific Officer of Tempus, are positioning the startup around what they call “cognitive longevity.” Their approach blends AI, advanced diagnostics, and nutritional science to tackle neuroinflammation and cognitive decline. The timing reflects both rising consumer demand for brain health solutions and investor attention to science-backed wellness brands.
BEVIMI’s first product, slated for release next year, is designed as nutritional support for individuals at risk of Alzheimer’s disease. Unlike typical supplements, it will undergo an IRB-approved, double-blind clinical trial to evaluate safety and key biomarkers tied to cognitive decline. By applying pharmaceutical-style rigor to consumer wellness, the founders aim to differentiate BEVIMI in a crowded market while pursuing a long-term vision of products that support focus, sleep, mood, and mental acuity. With headquarters in Greenwich, Connecticut, and a team of seasoned scientists, BEVIMI is entering the wellness sector with ambitions to bring biotech discipline to everyday brain health.
